Kala Pharmaceuticals, Inc. Stock price
Is Kala Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Kala Pharmaceuticals, Inc. Stock Analysis
Analyst Opinions
6 Analysts have issued a Kala Pharmaceuticals, Inc. forecast:
Analyst Opinions
6 Analysts have issued a Kala Pharmaceuticals, Inc. forecast:
Don't miss a Thing! We will send you all news about Kala Pharmaceuticals, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Kala Pharmaceuticals, Inc. Stock News
Company Profile
Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.
| Head office | United States |
| CEO | Mr. Minkowitz |
| Employees | 6 |
| Founded | 2009 |
| Website | www.kalarx.com |


